2.500
−3,85%
2026-10-16
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -5781.0% | -1846.3% | 2 / 3 | +93.5% | +3.65 pp | -7.64 pp | +39.2% | -12.60 | — | 66,3 | +93,5% | −5,2 | −5.781,0% | — | -0.46 | — |
| Pts | 0 | 0 | 8 | 12 | 12 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 2.500 (close price on 2026-10-16)EPS (TTM): −561,7
Financial charts
1.Revenue & growth
VND bn66,3Q2/26
1.Revenue & growth
VND bn66,3Q2/26
2.Profit & growth
VND bn-5,24Q2/26
3.Profit mix (Penman)
VND bn-5,79Q2/26
4.Margins & cost structure
%22.1%Q2/26
5.Returns & cash cycle
% · days8.1%Q2/26
6.Earnings quality & cash
VND bn32,8Q2/26
7.Asset structure
VND bn620Q2/26
8.Funding & debt health
VND bn · times620Q2/26
9.Revenue backlog
VND bn1,89Q2/26
10.Valuation
times · %-3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-509Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26